Methylprednisolone Terminated Phase 1 Trials for Myasthenia Gravis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00424489Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis